Investment
Features
FeesSafety
Academy
More
Pluang+

NeuroSense advances ALS drug PrimeC with key regulatory filings and positive trial results in 2026

Market News
25 Sep 2026
PRNewsWire
View Source
Bullish
NeuroSense advances ALS drug PrimeC with key regulatory filings and positive trial results in 2026

NeuroSense Therapeutics is progressing its ALS treatment PrimeC through regulatory steps in Canada and the U.S., targeting a Canadian New Drug Submission by December 2026. The company reported positive Phase 2b trial results showing significant survival benefits and biomarker improvements, reinforcing PrimeC's potential to slow ALS progression. NeuroSense is optimizing its U.S. development strategy, including discussions with the FDA on approval pathways, while pursuing financing and strategic partnerships to support ongoing development. These advances highlight NeuroSense's commitment to addressing the unmet need in ALS treatment.

NeuroSense Therapeutics business update is presented here with Pluang's health sector market data as of Sep 26, 2026 03:22 WIB. Of 100 priced health-sector US stocks tradable on Pluang, 53 rose and 47 fell today. Notable movers include Tenet Healthcare Corporation (THC) at USD 260.26 with a 1-day change of +4.30%, Recursion Pharmaceuticals Inc (RXRX) at USD 3.74 down -3.86%, and Enveric Biosciences Inc (ENVB) at USD 1.49 down -3.56%.

More News

Masonglory, INLIF, and Apimeds stocks surge on strategic deals and strong results

Masonglory, INLIF, and Apimeds stocks surge on strategic deals and strong results

Masonglory Limited's shares soared over 300% following its share swap deal to acquire a 20% stake in an Austrian construction firm, expanding its business scope. INLIF Limited gained about 74% after reporting strong first-half fiscal 2026 results wit...

Market News
Bullish
56 minutes ago
Gerdau S.A. shows strong fundamentals and analyst price targets suggest 20%+ upside potential.

Gerdau S.A. shows strong fundamentals and analyst price targets suggest 20%+ upside potential.

Gerdau S.A., a leading steel producer in the Americas, demonstrates solid financial health with a Piotroski Score of 8, indicating strong profitability, leverage, liquidity, and efficiency. Despite exposure to steel market volatility, analysts remain...

Analyst Insights
Bullish
1 hour ago
Sandisk rated Buy with strong contracts and cash flow despite high YTD gains and low valuation.

Sandisk rated Buy with strong contracts and cash flow despite high YTD gains and low valuation.

Sandisk Corporation is rated a Buy due to its multi-year contracts that secure over four years of demand and strong free cash flow. The company’s new business model guarantees minimum pricing and volume commitments, covering half of its 2027 chip sal...

Analyst Insights
Bullish
4 hours ago
Gold prices struggle under rising Treasury yields and Fed rate hike fears, holding near $4,300 amid geopolitical tensions.

Gold prices struggle under rising Treasury yields and Fed rate hike fears, holding near $4,300 amid geopolitical tensions.

Gold prices faced pressure this week, dropping from a high of $4,387 to a low near $4,245 per ounce due to rising U.S. Treasury yields, hawkish Federal Reserve rate hike expectations, and ongoing inflation concerns linked to energy costs and Middle E...

Market News
Neutral
4 hours ago
Two separate projects aim to enable USDT settlements on Bitcoin but lack broad consumer launch dates.

Two separate projects aim to enable USDT settlements on Bitcoin but lack broad consumer launch dates.

Tether and Utexo are independently developing infrastructure to support Tether USDt (USDT) settlements on Bitcoin using different technical methods. Tether plans to integrate USDT with Bitcoin’s base layer and Lightning Network via Taproot Assets for...

Protocol Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App